Inhibition of lymphotoxin-β receptor-mediated cell death by survivin-ΔEx3

Ren In You, Mei Chieh Chen, Hsei Wei Wang, Yang Chieh Chou, Chi Hung Lin, Shie Liang Hsieh

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

TNFSF14/LIGHT is a member of the tumor necrosis factor superfamily that binds to lymphotoxin-β receptor (LTβR) to induce cell death via caspase-dependent and caspase-independent pathways. It has been shown that cellular inhibitor of apoptosis protein-1 inhibits cell death by binding to LTβR-TRAF2/TRAF3 complexes and caspases. In this study, we found that both Kaposi's sarcoma-associated herpesvirus K7 (KSHV-K7), a viral inhibitor of apoptosis protein, and the structurally related protein survivin-ΔEx3 could inhibit LTβR-mediated caspase-3 activation. However, only survivin-ΔEx3 could protect cells from LTβR-mediated cell death. The differential protective effects of survivin-ΔEx3 and KSHV-K7 can be attributed to the fact that survivin-ΔEx3, but not KSHV-K7, is able to maintain mitochondrial membrane potential and inhibit second mitochondria-derived activator of caspase/DIABLO release. Moreover, survivin-ΔEx3 is able to inhibit production of reactive oxygen species and can translocate from nucleus to cytosol to associate with apoptosis signal-regulating kinase 1 after activation of LTβR. Furthermore, survivin-ΔEx3 protects LTβR-mediated cell death in caspase-3-deficient MCF-7 cells. Thus, survivin-ΔEx3 is able to regulate both caspase-dependent and caspase-independent pathways, whereas inhibition of caspase-independent pathway is both sufficient and necessary for its protective effect on LTβR-mediated cell death.

Original languageEnglish
Pages (from-to)3051-3061
Number of pages11
JournalCancer Research
Volume66
Issue number6
DOIs
Publication statusPublished - Mar 15 2006

Fingerprint

Lymphotoxin-alpha
Caspases
Cell Death
Human Herpesvirus 8
Inhibitor of Apoptosis Proteins
Caspase 3
TNF Receptor-Associated Factor 3
MAP Kinase Kinase Kinase 5
TNF Receptor-Associated Factor 2
Mitochondrial Membrane Potential
MCF-7 Cells
Cytosol
Reactive Oxygen Species
Mitochondria
Tumor Necrosis Factor-alpha
Light

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Inhibition of lymphotoxin-β receptor-mediated cell death by survivin-ΔEx3. / You, Ren In; Chen, Mei Chieh; Wang, Hsei Wei; Chou, Yang Chieh; Lin, Chi Hung; Hsieh, Shie Liang.

In: Cancer Research, Vol. 66, No. 6, 15.03.2006, p. 3051-3061.

Research output: Contribution to journalArticle

You, Ren In ; Chen, Mei Chieh ; Wang, Hsei Wei ; Chou, Yang Chieh ; Lin, Chi Hung ; Hsieh, Shie Liang. / Inhibition of lymphotoxin-β receptor-mediated cell death by survivin-ΔEx3. In: Cancer Research. 2006 ; Vol. 66, No. 6. pp. 3051-3061.
@article{ba4dcb8247234c7181dd382331a2049b,
title = "Inhibition of lymphotoxin-β receptor-mediated cell death by survivin-ΔEx3",
abstract = "TNFSF14/LIGHT is a member of the tumor necrosis factor superfamily that binds to lymphotoxin-β receptor (LTβR) to induce cell death via caspase-dependent and caspase-independent pathways. It has been shown that cellular inhibitor of apoptosis protein-1 inhibits cell death by binding to LTβR-TRAF2/TRAF3 complexes and caspases. In this study, we found that both Kaposi's sarcoma-associated herpesvirus K7 (KSHV-K7), a viral inhibitor of apoptosis protein, and the structurally related protein survivin-ΔEx3 could inhibit LTβR-mediated caspase-3 activation. However, only survivin-ΔEx3 could protect cells from LTβR-mediated cell death. The differential protective effects of survivin-ΔEx3 and KSHV-K7 can be attributed to the fact that survivin-ΔEx3, but not KSHV-K7, is able to maintain mitochondrial membrane potential and inhibit second mitochondria-derived activator of caspase/DIABLO release. Moreover, survivin-ΔEx3 is able to inhibit production of reactive oxygen species and can translocate from nucleus to cytosol to associate with apoptosis signal-regulating kinase 1 after activation of LTβR. Furthermore, survivin-ΔEx3 protects LTβR-mediated cell death in caspase-3-deficient MCF-7 cells. Thus, survivin-ΔEx3 is able to regulate both caspase-dependent and caspase-independent pathways, whereas inhibition of caspase-independent pathway is both sufficient and necessary for its protective effect on LTβR-mediated cell death.",
author = "You, {Ren In} and Chen, {Mei Chieh} and Wang, {Hsei Wei} and Chou, {Yang Chieh} and Lin, {Chi Hung} and Hsieh, {Shie Liang}",
year = "2006",
month = "3",
day = "15",
doi = "10.1158/0008-5472.CAN-05-2479",
language = "English",
volume = "66",
pages = "3051--3061",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Inhibition of lymphotoxin-β receptor-mediated cell death by survivin-ΔEx3

AU - You, Ren In

AU - Chen, Mei Chieh

AU - Wang, Hsei Wei

AU - Chou, Yang Chieh

AU - Lin, Chi Hung

AU - Hsieh, Shie Liang

PY - 2006/3/15

Y1 - 2006/3/15

N2 - TNFSF14/LIGHT is a member of the tumor necrosis factor superfamily that binds to lymphotoxin-β receptor (LTβR) to induce cell death via caspase-dependent and caspase-independent pathways. It has been shown that cellular inhibitor of apoptosis protein-1 inhibits cell death by binding to LTβR-TRAF2/TRAF3 complexes and caspases. In this study, we found that both Kaposi's sarcoma-associated herpesvirus K7 (KSHV-K7), a viral inhibitor of apoptosis protein, and the structurally related protein survivin-ΔEx3 could inhibit LTβR-mediated caspase-3 activation. However, only survivin-ΔEx3 could protect cells from LTβR-mediated cell death. The differential protective effects of survivin-ΔEx3 and KSHV-K7 can be attributed to the fact that survivin-ΔEx3, but not KSHV-K7, is able to maintain mitochondrial membrane potential and inhibit second mitochondria-derived activator of caspase/DIABLO release. Moreover, survivin-ΔEx3 is able to inhibit production of reactive oxygen species and can translocate from nucleus to cytosol to associate with apoptosis signal-regulating kinase 1 after activation of LTβR. Furthermore, survivin-ΔEx3 protects LTβR-mediated cell death in caspase-3-deficient MCF-7 cells. Thus, survivin-ΔEx3 is able to regulate both caspase-dependent and caspase-independent pathways, whereas inhibition of caspase-independent pathway is both sufficient and necessary for its protective effect on LTβR-mediated cell death.

AB - TNFSF14/LIGHT is a member of the tumor necrosis factor superfamily that binds to lymphotoxin-β receptor (LTβR) to induce cell death via caspase-dependent and caspase-independent pathways. It has been shown that cellular inhibitor of apoptosis protein-1 inhibits cell death by binding to LTβR-TRAF2/TRAF3 complexes and caspases. In this study, we found that both Kaposi's sarcoma-associated herpesvirus K7 (KSHV-K7), a viral inhibitor of apoptosis protein, and the structurally related protein survivin-ΔEx3 could inhibit LTβR-mediated caspase-3 activation. However, only survivin-ΔEx3 could protect cells from LTβR-mediated cell death. The differential protective effects of survivin-ΔEx3 and KSHV-K7 can be attributed to the fact that survivin-ΔEx3, but not KSHV-K7, is able to maintain mitochondrial membrane potential and inhibit second mitochondria-derived activator of caspase/DIABLO release. Moreover, survivin-ΔEx3 is able to inhibit production of reactive oxygen species and can translocate from nucleus to cytosol to associate with apoptosis signal-regulating kinase 1 after activation of LTβR. Furthermore, survivin-ΔEx3 protects LTβR-mediated cell death in caspase-3-deficient MCF-7 cells. Thus, survivin-ΔEx3 is able to regulate both caspase-dependent and caspase-independent pathways, whereas inhibition of caspase-independent pathway is both sufficient and necessary for its protective effect on LTβR-mediated cell death.

UR - http://www.scopus.com/inward/record.url?scp=33645531325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645531325&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-2479

DO - 10.1158/0008-5472.CAN-05-2479

M3 - Article

C2 - 16540654

AN - SCOPUS:33645531325

VL - 66

SP - 3051

EP - 3061

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 6

ER -